Rheumatology.net

Rheumatology Xagena

Search results for "Etanercept"

Long-term use of anti-TNF-alpha agents can lead to the development of autoantibodies. Infliximab ( Remicade ) is a chimeric human-murine monoclonal antibody that inhibits TNF-alpha. Investigator ...


A prospective cohort study found that Tumour Necrosis Factor alpha ( TNF-alpha ) blocking agents, trigger skin conditions in 25% of patients with rheumatoid arthtitis. TNF-alpha blocking agents has ...


Combined treatment with Adalimumab ( Humira ) and Methotrexate is about five times more effective than Methotrexate alone in people with long-standing rheumatoid arthritis. In six randomized contro ...


Data from a long-term blinded study of anti-TNF agent in patients with rheumatoid arthritis demonstrated that more than three quarters of patients treated with Enbrel ( Etanercept ) plus Methotrexate ...


Any form of arthritis that affects one or more vertebral joints, spondylarthritis ( SpA ) represents a group of closely related disorders, including ankylosing spondylitis ( AS ), psoriatic arthriti ...


A chronic autoimmune disease, rheumatoid arthritis is characterized by persistent inflammation of the synovial membrane and progressive joint destruction. Beyond loss of mobility, sufferers face a hig ...


To manage the painful and incapacitating symptoms of rheumatoid arthritis ( RA ), a chronic, inflammatory joint disease, the majority of patients rely on disease-modifying antirheumatic drugs ( DMARDs ...


Data presented at the European League Against Rheumatism Annual Congress ( EULAR 2014 ) have demonstrated the possibility of using biomarkers ( developed from whole blood gene expression profiles ) in ...


The European Commission ( EC ) has granted a licence extension for Enbrel ( Etanercept ) in the treatment of adult patients with severe non-radiographic axial spondyloarthritis ( nr-axSpA ). Non-ra ...


Etanercept ( Enbrel ) has been widely applied in the treatment of ankylosing spondylitis ( AS ). Previous meta-analyses have focused on comparing the differences in clinical outcomes between Etanercep ...


The aim of the study was to assess efficacy and safety of TNF-alpha antagonists ( anti-TNF ) in a cohort of patients with juvenile idiopathic arthritis ( JIA ) who began treatment under 4 years old an ...


Interleukin-17A ( IL-17A ) is a key cytokine in the pathogenesis of psoriatic disease of the skin and joints. In phase 3 trials, Secukinumab ( Cosentyx ), a fully human anti-IL-17A monoclonal antibody ...


A study has described the long-term adherence, efficacy, and safety in patients with psoriatic arthritis ( PsA ) treated with Etanercept ( Enbrel ) in a daily clinical setting in Belgium. The PROVE ...